Cel-Sci
CVM
#9766
Rank
$51.55 M
Marketcap
$6.45
Share price
2.54%
Change (1 day)
-61.61%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : $13.31 Million USD

According to Cel-Sci 's latest financial reports the company's total liabilities are $13.31 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30$14.12 M-18.42%
2023-09-30$17.31 M-5.7%
2022-09-30$18.36 M-5.04%
2021-09-30$19.33 M-7.08%
2020-09-30$20.8 M-7.47%
2019-09-30$22.48 M-23.99%
2018-09-30$29.58 M12.66%
2017-09-30$26.26 M2.72%
2016-09-30$25.56 M-23.26%
2015-09-30$33.31 M279.15%
2014-09-30$8.78 M112.33%
2013-09-30$4.13 M-54.22%
2012-09-30$9.04 M-5.31%
2011-09-30$9.54 M-4.06%
2010-09-30$9.95 M-73.24%
2009-09-30$37.18 M866.49%
2008-09-30$3.84 M-36.52%
2007-09-30$6.06 M-42.74%
2006-09-30$10.58 M971.99%
2005-09-30$0.98 M-29.05%
2004-09-30$1.39 M-17.67%
2003-09-30$1.69 M-37.61%
2002-09-30$2.7 M433.57%
2001-09-30$0.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Curis
CRIS
$42.33 M 218.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$0.83 B 6,167.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$80.52 B 604,814.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$0.24 B 1,729.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.60 B 244,819.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
$113.53 B 852,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.87 B 6,499.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$2.6 M-80.45%๐Ÿ‡บ๐Ÿ‡ธ USA